DCPH Company Profile and Key Details
Deciphera Pharmaceuticals, Inc.
DCPH Stock Price Chart
Stock Price Today
Deciphera Pharmaceuticals, Inc. (DCPH) stock surged +0.08%, trading at $25.59 on NASDAQ, up from the previous close of $25.57. The stock opened at $25.56, fluctuating between $25.56 and $25.61 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gastrointestinal stromal tumors (GIST), as well as in INTRIGUE Phase 3 study to treat second-line GIST. The company is also developing vimseltinib, an orally administered, potent, and highly selective switch-control kinase inhibitor of colony stimulating factor 1 receptor (CSF1R) for the treatment of tenosynovial giant cell tumor (TGCT); and DCC-3116 to treat RAS/RAF mutant cancers that is in the preclinical-stage. Deciphera Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Waltham, Massachusetts.
Company Information
| Employees | 355 |
| Beta | 0.18 |
| Sales or Revenue | $163.36M |
| 5Y Sales Change% | 0% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
Frequently Asked Questions
Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH) stock price is $25.59 in the last trading session. During the trading session, DCPH stock reached the peak price of $25.61 while $25.56 was the lowest point it dropped to. The percentage change in DCPH stock occurred in the recent session was 0.08% while the dollar amount for the price change in DCPH stock was $0.02.
The NASDAQ listed DCPH is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector. Deciphera Pharmaceuticals, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Dr. Daniel L. Flynn Ph.D.
Executive Vice President, Chief Scientific Officer & Founder
Mr. Steven L. Hoerter
Pres, Chief Executive Officer & Director
Dr. Stephen B. Ruddy Ph.D.
Senior Vice President & Chief Technical Officer
Mr. Thomas Patrick Kelly J.D.
Executive Vice President, Chief Financial Officer & Treasurer
Jennifer Larson
Senior Vice President of Fin. & Investor Relations
Mr. Jeffrey M. Held J.D.
Senior Vice President & Gen. Counsel
Dr. Matthew L. Sherman M.D.
Executive Vice President & Chief Medical Officer
Mr. Daniel C. Martin
Senior Vice President & Chief Commercial Officer
Ms. Jama Pitman
Senior Vice President of Regulatory, Quality & Portfolio Management
DCPH's closing price is 158.49% higher than its 52-week low of $9.90 where as its distance from 52-week high of $25.61 is -0.08%.
Number of DCPH employees currently stands at 355.
Official Website of DCPH is: https://www.deciphera.com
DCPH could be contacted at phone 781 209 6400 and can also be accessed through its website. DCPH operates from 200 Smith Street, Waltham, MA 02451, United States.
DCPH stock volume for the day was 1.57M shares. The average number of DCPH shares traded daily for last 3 months was 1.86M.
The market value of DCPH currently stands at $2.21B with its latest stock price at $25.59 and 86.48M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com